Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Angiotensin receptor-neprilysin inhibitor improves New York Heart Association class and N-terminal-pro B-type natriuretic peptide levels: initial experience in a Singapore single-centre cohort.

× No keyword cloud information.

9 in total

1. Pharmacokinetics of fosinoprilat in Chinese and whites after intravenous administration.

Authors: O Y Hu; P Y Ding; C S Huang; G M Hwang; K M Chu
Journal: J Clin Pharmacol Date: 1997-09 Impact factor: 3.126

2. Renin-angiotensin-aldosterone system gene polymorphisms and hypertension in Hong Kong Chinese.

Authors: G N Thomas; R P Young; B Tomlinson; K S Woo; J E Sanderson; J A Critchley
Journal: Clin Exp Hypertens Date: 2000-01 Impact factor: 1.749

3. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal: J Am Coll Cardiol Date: 2016-05-20 Impact factor: 24.094

4. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific).

Authors: John J Atherton; Christopher S Hayward; Wan Azman Wan Ahmad; Bernard Kwok; Jesus Jorge; Adrian F Hernandez; Li Liang; Robb D Kociol; Henry Krum
Journal: J Card Fail Date: 2011-10-08 Impact factor: 5.712

Review 5. Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors?

Authors: P Y Ding; O Y Hu; P E Pool; W Liao
Journal: J Hum Hypertens Date: 2000-03 Impact factor: 3.012

6. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan--first report from the CHART-2 study.

Authors: Nobuyuki Shiba; Kotaro Nochioka; Masanobu Miura; Haruka Kohno; Hiroaki Shimokawa
Journal: Circ J Date: 2011-03-20 Impact factor: 2.993

7. Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors: John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal: N Engl J Med Date: 2014-08-30 Impact factor: 91.245

8. A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers.

Authors: P J Anderson; J A Critchley; B Tomlinson
Journal: Eur J Clin Pharmacol Date: 1996 Impact factor: 2.953

9. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors: Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal: Eur Heart J Date: 2016-05-20 Impact factor: 29.983

9 in total